| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Chief Scientific Officer | Class A Common Stock | 1,097,151 | $3,829,056 | $3.49 | 17 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | 17 Feb 2026 | 1 | -$41,559 | 4 | Chief Scientific Officer | 19 Feb 2026, 19:30 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 06 Feb 2026 | 3 | -$45,372 | 4 | Chief Scientific Officer | 10 Feb 2026, 18:18 |
| RXRX | RECURSION PHARMACEUTICALS, INC. | 01 Jan 2026 | 0 | $0 | 3 | CSO | 09 Jan 2026, 19:18 |